As of close of business last night, Vera Therapeutics Inc’s stock clocked out at $45.15, down -2.99% from its previous closing price of $46.54. In other words, the price has decreased by -$1.39 from its previous closing price. On the day, 1255398 shares were traded. VERA stock price reached its highest trading level at $47.30 during the session, while it also had its lowest trading level at $43.83.
Ratios:
To gain a deeper understanding of VERA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.64 and its Current Ratio is at 6.64. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On December 18, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on December 18, 2023, with a $29 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 30 when Katabi Maha bought 161,290 shares for $31.00 per share. The transaction valued at 4,999,990 led to the insider holds 3,628,446 shares of the business.
COMMODORE CAPITAL LP sold 1,050,000 shares of VERA for $18,900,000 on Jan 10. The 10% Owner now owns 4,400,000 shares after completing the transaction at $18.00 per share. On Aug 21, another insider, Fordyce Marshall, who serves as the President and CEO of the company, sold 5,210 shares for $16.66 each. As a result, the insider received 86,779 and left with 243,361 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2.42B and an Enterprise Value of 2.29B.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $50.78, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 30.03, while the 200-Day Moving Average is calculated to be 18.11.
Shares Statistics:
It appears that VERA traded 1.18M shares on average per day over the past three months and 1.05M shares per day over the past ten days. A total of 53.71M shares are outstanding, with a floating share count of 37.68M. Insiders hold about 29.85% of the company’s shares, while institutions hold 61.49% stake in the company. Shares short for VERA as of Feb 15, 2024 were 6.77M with a Short Ratio of 5.72, compared to 6.05M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 12.60% and a Short% of Float of 15.77%.
Earnings Estimates
As of right now, 9 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.51 for the current quarter, with a high estimate of -$0.42 and a low estimate of -$0.58, while EPS last year was -$1.18. The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.43 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$2.06 and -$2.28 for the fiscal current year, implying an average EPS of -$2.19. EPS for the following year is -$2.15, with 9 analysts recommending between -$1.74 and -$2.77.
